Financials

  • Market Capitalization 70.59 M
  • Employee 49
  • Founded 2015
  • CEO N/A
  • Website www.pliantrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00C8083N4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.5
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4152
IBIO
iBio, Inc. - Common Stock
1.45 USD-3.97%-12.12%-15.20%-36.96%72.03 M USD
4155
XBIT
XBiotech Inc. - Common Stock
2.33 USD+1.75%-2.10%-1.69%-19.66%71.04 M USD
4166
IMA
ImageneBio, Inc. - Common Stock
6.11 USD+3.38%+2.52%+5.34%-66.06%68.92 M USD
4171
PMVP
PMV Pharmaceuticals, Inc. - Common Stock
1.28 USD+3.23%+4.07%+15.32%-3.76%68.26 M USD

Frequently asked questions about Pliant Therapeutics, Inc. - Common Stock

What is the Pliant Therapeutics, Inc. - Common Stock stock price today?

The current price of Pliant Therapeutics, Inc. - Common Stock (PLRX) is 1.1400000000000001. Over the past 24 hours, the stock has changed by +1.79%. Follow the PLRX chart for real-time price dynamics.

What is the stock ticker of Pliant Therapeutics, Inc. - Common Stock?

Pliant Therapeutics, Inc. - Common Stock trades under the ticker PLRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Pliant Therapeutics, Inc. - Common Stock stock going up?

PLRX has changed by -0.87% over the last week, -1.72% over the last month, and -21.38% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Pliant Therapeutics, Inc. - Common Stock net income for the last quarter?

Pliant Therapeutics, Inc. - Common Stock reported net income of -20.04 M for the last quarter. The previous quarter showed -23.58 M, which means net income changed by +15.00%.

How many employees does Pliant Therapeutics, Inc. - Common Stock have?

As of the latest available data, Pliant Therapeutics, Inc. - Common Stock has 49 employees. Workforce size can provide additional context about the company's scale and operations.

What is Pliant Therapeutics, Inc. - Common Stock EBITDA?

Pliant Therapeutics, Inc. - Common Stock EBITDA is -21.41 M, and its EBITDA margin is -22.78 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Pliant Therapeutics, Inc. - Common Stock stock?

You can buy Pliant Therapeutics, Inc. - Common Stock (PLRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Pliant Therapeutics, Inc. - Common Stock stock?

Investing in Pliant Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PLRX chart and related analysis on metatrader.com as part of your research.

News